Related Experiment Video
Updated: Jan 27, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Validation of pneumococcal iron acquisition (piaA) gene for accurate identification of Streptococcus pneumoniae
Sreeram Chandra Murthy Peela1, Sujatha Sistla1, Kadhiravan Tamilarasu2
1Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Insights
The piaA gene shows high specificity for identifying pneumococci, making it a potential diagnostic marker. However, its sensitivity is moderate, requiring further large-scale studies for conclusive evidence.
Area of Science:
- Microbiology
- Molecular Diagnostics
Background:
- Streptococcus pneumoniae causes significant global health burdens.
- Accurate and rapid identification of pneumococci is crucial for effective treatment and public health surveillance.
- The pneumococcal iron acquisition (piaA) gene has been proposed as a highly specific marker for pneumococcal identification.
Purpose of the Study:
- To evaluate the efficacy of the piaA gene as a genetic marker for the identification of pneumococci.
- To assess the sensitivity and specificity of piaA-based polymerase chain reaction (PCR) for pneumococcal detection.
Main Methods:
- Initial sequencing of the lytA gene for 20 isolates.
- Development and application of a piaA-specific PCR assay using in-house primers and protocol.
- Selection of 30 pneumococcal and 11 non-pneumococcal isolates based on initial results for further testing.
- Statistical analysis of sensitivity, specificity, and agreement using OpenEpi v3.01 and GraphPad Quickcalc.
Main Results:
- The piaA PCR demonstrated 100% specificity in initial testing of non-pneumococcal isolates.
- Sensitivity for piaA PCR was 71.43% for pneumococcal isolates in initial testing, increasing to 73.33% when tested on a larger sample size (41 samples).
- A moderate level of agreement (κ = 0.694) was observed between piaA PCR and lytA sequencing.
Conclusions:
- The piaA gene serves as a specific genetic marker for pneumococcal identification.
- While specific, the piaA PCR assay exhibits moderate sensitivity, suggesting limitations for sole diagnostic use.
- Further extensive research with larger sample cohorts is recommended to definitively establish piaA as a reliable diagnostic marker for pneumococcus.
Purpose:
The pneumococcal iron acquisition (piaA) gene is found to be highly specific and hence proposed as a diagnostic marker for identification of pneumococci. The objective of the present study was to evaluate the piaA gene as a genetic marker for the identification of pneumococci.
Methods:
Twenty isolates were initially sequenced for lytA gene using published primers. PiaA-PCR (piaA polymerase chain reaction) was performed using in-house primers and protocol. Based on the sensitivity and specificity results, a final sample of 30 pneumococcal isolates and 11 non-pneumococcal isolates confirmed with lytA- sequencing were selected. Statistical analyses were performed using OpenEpi v3.01 and GraphPad Quickcalc at P < 0.05 as the level of statistical significance.
Results:
Of the initial 20 samples tested, piaA PCR was positive in only 71.43% (10/14) of the pneumococcal isolates but was 100% specific (0/6 non-pneumococcal isolates) P = 0.011. When the PCR was performed on 41 samples, the sensitivity increased to 73.33% (95% of confidence interval [CI] = 55.55-85.82) and specificity remained the same P < 0.001. The level of agreement between the PCR and lytA-sequencing was found to be moderate (κ = 0.694; 95% CI = 0.432-0.955).
Conclusions:
PiaA-PCR can be used as a specific marker for the identification of pneumococcus, though it is less sensitive. As the level of agreement was moderate, further analyses on a large number of samples can give conclusive evidence for its use as a diagnostic marker for pneumococcus.
More Related Videos
Related Concept Videos
Reliability and Validity
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Data Validation
Key parameters for method validation include:

